Nectar Lifesciences shares jump 18% after announcing a buyback at a 51% premium

Shares of Nectar Lifesciences Ltd. gained over 18% on Thursday, December 4, after the company's board on Wednesday announced an ₹81-crore share buyback.

The record date to determine the shareholder eligibility has been fixed for December 24, 2025.

The firm will repurchase 3 crore fully paid-up equity shares at ₹27 apiece via the tender offer route, representing up to 13.38% of its paid-up equity capital. The buyback price is a premium of 51% compared to Wednesday's closing price.

The buyback size is within the 10% limit of its total paid-up capital and free reserves, based on the FY25 audited financials.

As per the company's exchange filing, the buyback will be open to all shareholders except promoters and promoter group members, who have formally expressed their intention not to participate.

Nectar Lifesciences has appointed Master Capital Services Ltd. as the manager for the buyback.

Nectar Lifesciences reported a 98.83% decline in its net sales to ₹5 crore from ₹428.1 crore in the previous year.

It reported a net loss of ₹176.01. crore in the second quarter compared to a loss of ₹5.6 crore in the previous year. Its earnings before interest tax depreciation and amortisation (EBITDA) turned negative at ₹0.31 crore, down from ₹44.02 crore in the year-ago period.

Shares of Nectar Life were up 18.4% at ₹21.16 apiece around 11 am. The stock has gained 45.5% in the past month and has declined 48.7% this year, so far.

Also Read: Bajaj Housing Finance shares are at a 52-week low, but has the stock made a bottom?